Category: Discussions
US-funded measurements of cervical cancer death rates in…
Background: Since 1998, randomised trials in India funded by the US National Cancer Institute (NCI) and the Bill and Melinda Gates Foundation have compared cervical cancer death rates among 224,929 women offered cervical screening to those among 138,624 women offered no screening whatsoever. To d...
Response to article titled “US-funded measurements of cervical…
Dr Eric Suba has been distorting facts and persistently disseminating biased and misleading views and statements regarding our studies over the past several years. His article in the Indian Journal of Medical Ethics fails to mention the facts that seem unfavourable to his arguments, and the ethic...
Response by Eric Suba to Sankaranarayanan et al
During the 1970s and 1980s, reports from several countries documented substantial reductions in incidence rates of cervical cancer and death rates following the introduction of cervical screening and confirmed the role of cervical screening as an archetypal preventive health intervention; moreove...
Have scientists met their ethical responsibility towards research…

Pramesh and colleagues  have not responded to my central thesis: it was unethical to have a "no screening" control arm in the VIA trials when proven screening methods existed

Ethical issues in adapting new technologies for rapid…

The Xpert® MTB/RIF (hereafter Xpert) is a recent technology that has "demonstrated sensitive detection of tuberculosis (TB) and rifampicin resistance directly from untreated sputum in less than two hours" . Many are in favour of the widespread implementation of this technology in India. In a r...

Ethics of “standard care” in randomised trials of…

We read with interest the recent editorial  in the IJME on the ethics of standard care in screening trials for cervical cancer in India. The author takes exception to the fact that three cervical cancer screening studies in India used no screening as the control arm, in spite of evidence that ...

Issues in the care of the dying
There is rejuvenated interest within modern medicine in end-of-life issues including the care of terminally ill and dying patients. Technological advances in the last few decades have made us believe that death is an unnatural event and that life can be prolonged at will. This has resulted in the...
Socio-ethical issues in the deployment of life-extending technologies
As medical practice becomes increasingly technology oriented, health-care expenditure has also increased significantly . At the same time, there have long been calls that medical technologies like other social goods should be distributed by rational criteria, especially when resources are scarce.
End-of-life issues neglected in India
As an invasive cardiologist in the US I deal with end-of-life issues almost daily. It is my experience that many elderly patients survive cardiac arrests with a very poor quality of life or in a vegetative state. I have seen too many such patients living a miserable life for months in a hospital ...
Issues faced by a hospice
As one reaches the final station of life, there is a plethora of issues that we confront, involving the patient, the family and the caregiver. While much work has been done on the joyous beginning of life, death is a neglected subject.
Previous 1  2  3  4  5  6  ... 14  Next


Help IJME keep its content free. You can support us from as little as Rs. 500 Make a Donation